GOLPH3 has been identified as an oncoprotein and is significantly upregulated in prostate cancer [57], esophageal cancer [58], gastric cancer [59], ovarian cancer [60], and colon cancer [61]. Here, GOLPH3 is linked to prostate carcinoma.